0000899243-21-007106.txt : 20210218 0000899243-21-007106.hdr.sgml : 20210218 20210218160516 ACCESSION NUMBER: 0000899243-21-007106 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210205 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lebowitz Joel CENTRAL INDEX KEY: 0001797829 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 21649501 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-02-05 2021-02-08 0 0001490978 Schrodinger, Inc. SDGR 0001797829 Lebowitz Joel C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 See Remarks Common Stock 2021-02-05 4 S 0 1115 99.8977 D 0 D This amendment is being filed solely to correct the transaction code from "P" to "S" for the sale of shares of common stock in connection with the transaction reported in the Form 4 filed by the reporting person on February 8, 2021. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.60 to $100.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4/A. Executive Vice President and Chief Financial Officer /s/ Donald Shum, as attorney-in-fact for Joel Lebowitz 2021-02-18